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Abstract
Eosinophils are important in fighting parasitic infections and are implicated in the pathogenesis of
asthma and allergy. IL-5 is a critical regulator of eosinophil development, controlling proliferation,
differentiation, andmaturation of the lineage.Mice that constitutively express IL-5 have in excess
of 10-fold more eosinophils in the hematopoietic organs than their wild type (WT) counterparts.
Wehave identified thatmuchof this expansion is in apopulationof Siglec-Fhigheosinophils,which
are rare inWTmice. In this study,weassessed transcription inmyeloidprogenitors, eosinophil pre-
cursors, and Siglec-Fmedium and Siglec-F high eosinophils from IL-5 transgenic mice and in doing
so have created a useful resource for eosinophil biologists. We have then utilized these popula-
tions to construct an eosinophil trajectory based on gene expression and to identify gene sets that
are associated with eosinophil lineage progression. Cell cycle genes were significantly associated
with the trajectory, and we experimentally demonstrate an increasing trend toward quiescence
along the trajectory. Additionally, we found gene expression changes associated with constitutive
IL-5 signaling in eosinophil progenitors, many of which were not observed in eosinophils.
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1 INTRODUCTION
Eosinophils are granulocytes that play a role in the pathogenesis of
asthma, atopic dermatitis, and allergy. Although they have been asso-
ciated with defense against parasites such as helminths, it is their
pathogenic inflammatory role that has significant implications for
human health in the developedworld.
Eosinophils are produced in the bone marrow (BM) and differenti-
ate from myeloid progenitors in response to IL-3, GM-CSF, and more
selectively, IL-5.1,2 Although eosinophils are normally a rare popula-
tion, upon IL-5 stimulation, which can occur in response to a para-
sitic infection and inflammatory disease, the BM can produce several
orders of magnitude more eosinophils than are seen at steady state.
Transgenic mice that constitutively over express IL-5 (IL5T [IL-5 trans-
Abbreviations: BM, bonemarrow; CMP, commonmyeloid progenitor; DE, differentially expressed; EoH, Siglec-F High Eosinophils; EoM, Siglec-FMedium Eosinophils; EoP, eosinophil precursor;
EPX, eosinophil peroxidase; GMP, granulocyte-macrophage progenitor; GO, gene ontology; IL-5R𝛼, IL-5 receptor alpha; IL5T, IL-5 transgenic; PB, peripheral blood; Spln, spleen;WT, wild-type
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genic]: IL-5 is produced by T cells, under control of the CD2 promoter)
have a permanent and extreme eosinophilia, where eosinophils make
up over half of all leukocytes in the BM.3 IL-5 acts at multiple levels
throughout the eosinophil lineage, regulating eosinophil production,
activation, migration, and survival.3–6
Murine eosinophils can be identified using flow cytometry by their
granularity and their expression of IL-5 receptor alpha (IL-5R𝛼) and
the surface lectin Siglec-F.7,8 Siglec-F possesses an ITIM characteris-
tic of the Siglec family that can mediate inhibitory functions including
induction of apoptosis.9 In mouse models of allergy in which Siglec-
F ligand has been deleted from bronchial epithelial cells and some
immune cells, eosinophil populations are expanded due to reduced
apoptosis.10 Following stimulation in a lung allergy model, Siglec-F
expression increases on eosinophils in BM, peripheral blood (PB), and
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spleen (spln), marking them for clearance.11 Siglec-F has a functional
analogue in humans—Siglec-8—rather than a genuine paralogue,which
convergent evolution has filling a similar role.9
Novel therapies targeting IL-5 signaling are approved for the treat-
ment of eosinophilic asthma,12,13 and anti-IL-5 and anti-Siglec-8 ther-
apies are currently in development for the treatment of diverse
eosinophilic diseases.14–16
Here, we have studied the gene expression changes associatedwith
IL-5 up-regulation. We noted the expansion of 2 eosinophil popula-
tions in IL5T mice that were distinguished on the basis of medium
and high Siglec-F expression. We transcriptionally profiled these
populations inBMandblood andhavemade these transcriptional anal-
yses available at haemosphere.org. Transcriptional profiling and in sil-
ico approaches were used to reconstruct the eosinophil lineage (from
common myeloid progenitors (CMP) through to mature eosinophils),
and show that the Siglec-Fhi eosinophil population from the PB, which
is rare in wild type (WT) mice, falls at the end of this linear trajec-
tory. We identified gene sets that were associated with eosinophil
lineage progression and increased Siglec-F expression, which include
eosinophil specific transcription factors and cell cycle regulators.
Furthermore, eosinophils along this trajectory were shown to have
demonstrably different cell cycle profiles and to trend toward quies-
cence. Finally, we explored the transcriptional consequence of consti-
tutive IL-5 signaling on the lineage, noting gene expression changes
that were specific to eosinophil precursors (EoPs).
2 MATERIALS AND METHODS
2.1 Transgenicmice
All procedures involving animals were approved by The Walter and
Eliza Hall Institute of Medical Research Animal Ethics Committee.
IL5T mice were originally described in Ref. 3, where IL-5 is constitu-
tively expressed under the CD2 promoter. Mice that were used for
transcriptomicswereoriginally derivedonaBALB/c background,while
for the ELISA, cytocentrifuges, qRT-PCR, and flow cytometry popu-
lation quantifications they were backcrossed onto a C57BL/6 back-
ground for at least 9 generations. Fucci mice were originally described
in Ref. 17 andwere obtained from the Riken BioResource Centre.
2.2 Cell purification
All cells were purified from mice between 7 and 12 weeks of age. BM
was collected from femurs and tibiae. PBwas collected from the retro-
orbital sinus intoMicrotainer tubes containing EDTA (BDBiosciences).
Single-cell suspensions of Spln cells were prepared using a 100 𝜇m
cell strainer (BD Falcon). Red blood cells were lysed using an ammo-
nium chloride buffer. Samples were stained with surface antibodies to
Siglec-F (BD E50-2440), IL-5R𝛼 (BD T21), CCR3 (BioLegend Jo73E5),
cKit (BD2B8), CD34 (BDRAM34), Sca1 (D7), CD11b (in houseM1/70),
or a lineage cocktail of in-house CD3 (KT31-1), CD4 (GK1.5), CD8
(53-6-6), B220 (RA3-6B2),Gr1 (RB68C5), andTer119 (Ly-76), then iso-
lated on a fluorescence-activated cell sorter. Stained cells were ana-
lyzed on a BD LSR Fortessa X-20 flow cytometer (BD Biosciences) or
sorted on a BD FACS Aria III (BD Biosciences). Re-sort of sorted pop-
ulations showed average purity of 91%. Cell populations for sorting
for transcriptomics were defined using the following surface mark-
ers: eosinophils (IL-5R𝛼 Int, Siglec-F high or medium), CMP (Lin–,
cKit+, Sca1–, CD34+, and CD16/32lo), granulocyte-macrophage pro-
genitor (GMP; Lin–, cKit+, Sca1–, CD34+, CD16/32+, and IL-5R𝛼-),18
EoP (Lin–, cKit+, Sca1–, CD34+, CD16/32+, and IL-5R𝛼+). For FACS
analyses, EoPs were gated as per Supplementary Fig. 4 from Doyle
et al.19 (Lin–, Sca1–, CD34+, cKit lo, and IL-5R𝛼+), and eosinophil gat-
ing included the marker CD11b+. Prior to flow cytometry, cells were
resuspended in PBS supplemented with 2% FCS, 2 mMEDTA, 1 𝜇g/mL
propidium iodide (Sigma) to enable identification and exclusion of
dead cells.
Flow cytometric analyses were performed with FlowJo v10 soft-
ware (FlowJo). Subsequent statistical tests and graphswere generated
with Prism (GraphPad Software).
2.3 Data availability
All data can be viewed and are available for download on haemo-
sphere.org. The dataset is also available in the Gene Expression
Omnibus under the accession number GSE112010.
Full details of DNA content analyses, ELISA, microarray, cytocen-
trifuge, RNA isolation, RT qPCR, and bioinformatics analyses can be
found in the supplementarymethods.
3 RESULTS AND DISCUSSION
Cells of the eosinophil lineage are rare in hematopoietic tissues of
healthy WT mice but dramatically expanded in IL5T mice as has been
reported by Dent et al.3 We confirmed this expansion in BM, Spln,
and PB of IL5T mice, from EoPs to mature eosinophils (Fig. 1A and
B). In isolating eosinophils for transcriptional analyses in bothWT and
IL5Tmice,weobservedeosinophils expressingmedium levels of Siglec-
F (EoM)anda secondpopulationwithhigh levels of cell surfaceSiglec-F
(EoH) (Fig. 1A). These 2 eosinophil populations were visible in the PB,
Spln, and BM, andwe sought to characterize them further.
The relative abundance of EoM and EoH varied dramatically
depending on mouse genotype and tissue (Fig. 1B and C). In WT mice,
eosinophils were rare, making up 2.7% of the nucleated cells in the PB,
0.22% in the Spln, and 2.9% in the BM, with EoM cells outnumbering
EoH cells by a ratio of between 29:1 in the BM and 4:1 in the Spln. In
IL5T mice, although both EoM and EoHwere expanded in all 3 tissues,
the effectwasmore dramatic for EoH cells, whichwas observed at sim-
ilar levels toEoM in theBMandPB, andwas6-foldmoreabundant than
EoM cells in the Spln.
Flow cytometry analyses showed that side scatter, a measure of
the granular complexity of cells, was high in EoPs and all mature
eosinophil populations (Fig. 1D) irrespective of the level of Siglec-
F expression. To explore the morphology of these cells, we isolated
EoM and EoH populations from the C57BL/6 IL5T BM and PB, and
EoM fromWT C57BL/6 BM by FACS and examined the cells following
cytocentrifugation andMay–Grünwald Giemsa staining (Fig. 1E). Mor-
phologically, EoM and EoH resembled eosinophils, irrespective of the
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F IGURE 1 Eosinophil populations in IL5T mice. (A) Flow cytometry
profiles of eosinophils collected from the BM, PB, and Spln of WT and
IL5T mice. Populations have been gated for CD11b+ cells as shown.
All mice are on a C57BL/6 background. (B) Proportion of eosinophil
populations that make up the live cells in the BM, PB, and Spln. EoPs
were gated for live cells then Lin–, Sca1–, CD34+, cKit lo, and IL-5R𝛼+
19as shown in Supplementay Fig. 1. *p < 0.05, n = 3, mean ± SD shown.
(C) Ratio of EoH to EoM in different tissues, n = 3 for each genotype,
Mean ± SD shown. (D) Side scatter of eosinophil populations, n = 3,
mean± SD shown. (E) May–Grünwald Giemsa stained cytocentrifuged
preparations of WT and IL5T eosinophil populations viewed at 1000×
magnification. Two representative cells were chosen from prepara-
tions from 3 separatemice for each population
mouse genotype (C57BL/6 or IL5T) or the tissue fromwhich theywere
isolated. All sorted populations had brightly staining eosinophilic cyto-
plasm with hypersegmented, ring-shaped nuclei. We concluded that 2
populations of eosinophils were present in hematopoietic tissues of
mice, which are identifiable on the basis of Siglec-F expression and
expanded in IL5Tmice.
3.1 Cluster analysis of eosinophil and eosinophil
progenitor expression profiles
Given that EoH were expanded upon constitutive IL-5 stimulation
(IL5T mice) and have been reported but not characterized in allergy
models,11 it is possible they may play a role in disease. To explore the
relationship between this population and other cells in the eosinophil
lineage, we collected EoM and EoH from the BM and EoH from the
PB of IL5T mice and analyzed gene expression using microarrays. We
also collected EoPs, CMPs, and GMPs from WT and IL5T mice (Sup-
plementary Fig. 1). These cells were all on a BALB/c background. We
compared them to each other, and to transcriptional profiles of WT
C57BL/6 eosinophils (bulk sorted without Siglec-F substratification),
EoPs, CMPs, and GMPs that have been previously published by our
laboratory as part of a general survey of transcription in blood cells20
(Supplementary Table 1).
Hierarchical clustering of these samples showed that the progen-
itors all grouped by cell type, with little difference between “like”
cell types from different genetic backgrounds (Fig. 2A). Eosinophils
formed a separate cluster, within which the IL5T eosinophil sam-
ples clustered together by Siglec-F expression and tissue of origin.
C57BL/6 eosinophils formed a subcluster, rather than grouping with
the IL5T EoM, to which they were closest by surface phenotype, a dif-
ference which may be driven by the effect of chronic IL-5 stimulation
on these cells.
Multidimensional clustering of the average expression for each cell
type ordered the cells along a “reverse ‘U’-shaped” trajectory, begin-
ning with CMPs in the top right corner and ending with IL5T EoH
cells from the PB at the top left (Fig. 2B). In these analyses, the
C57BL/6 (C57) eosinophils BMwere positioned between the EoPs and
the IL5T eosinophils, with the IL5T EoM BM cells being most simi-
lar to the bulk sorted C57BL/6 BM eosinophils and the IL5T EoH PB
terminating the series.
To independently confirm both the ordering of cell types and their
arrangement in a linear trajectory, we created a minimum spanning
tree from the IL5T samples. This is an unsupervised technique which
links cell types with their nearest neighbor by Euclidean distance.
Although the algorithm allows for branching between cell types, in our
analyses we found the cell types formed a linear trajectory from CMP
through to EoH PB (Fig. 2C). Based on these results, we propose an
order for the IL5T eosinophil lineage: a linear trajectory from EoP to
EoMBM to EoHBM to EoH PB.
Together, these data support the notion that transcriptionally, EoH
are the terminal definable state in our eosinophil trajectory. We inter-
pret this as EoHs representing activated or stimulated eosinophils,
which are present in WT mice and driven by constitutive IL-5 stimu-
lation in IL5Tmice.
3.2 Identification of eosinophil trajectory genes
Having demonstrated the positioning of cells along a linear tra-
jectory, we hypothesized that as cells progress along the series
genes they would be gradually up- or down-regulated. We have
termed such genes “trajectory genes”. To identify trajectory genes,
we focused on genes that were differentially expressed (DE) between
(1) EoPs versus EoH BM cells and (2) EoM BM versus EoH PB
from IL5T mice. These comparisons spanned the key “eosinophil spe-
cific” parts of our developmental progression—as opposed to includ-
ing multi-potential progenitors such as CMPs and GMPs. We did not
compare the cells that were immediately adjacent to each other in
the series because adjacent cells were likely to have smaller transcrip-
tional differences and thus a higher background to signal ratio leading
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F IGURE 2 Transcriptional profiling of eosinophils and progenitors. (A) Hierarchical clustering of microarray samples using Euclidean distance.
Each row and column represents an independent replicate. (B)Multidimensional scaling plot of average eosinophil and progenitor populations. The
number of replicates for each group are as shown in (A). Strains and genotype ofmice are C57=WTC5LBL/6, BALB=WTBALB/c, and IL5T= IL5T
BALB/c. (C) Minimum spanning tree of average gene expression in IL5T progenitors and eosinophil populations. Euclidean distance between the
populations is shown
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F IGURE 3 Identification of genes up- or down-regulated across the IL5T eosinophil trajectory.Heatmap of genes that are (A) down-regulated
or (B) up-regulated across the IL5T eosinophil trajectory. (i) The eosinophil populations used to select the genes of interest. Genes are significantly
differentially expressed (DE) (log2FC > 0.5 and false discovery rate [FDR] < 0.05) in the same direction EoP versus EoH BM, and EoM BM versus
EoH PB. (ii) DE genes (log2FC> 0.5 and an FDR< 0.05) in EoP versus eosinophils according to Bouffi et al.
21 NonSig, not significantly different. (iii)
Expression levels of up- and down-regulated genes across hematopoiesis. Transcriptional profiles of other hematopoietic cell types are taken from
Haemopedia.20 LSK = Lin-Sca+Kit+ cell, NeutPt = peritoneal cavity neutrophil, Neut = bone marrow neutrophil, Baso = basophil, Mast = mast
cell, MonoPB = monocyte from the peripheral blood, Mac = macrophage, ResDC = resident dendritic cell, B2 = B2 B cell, EffCD8T = effector
CD8+ T cell, CD4TLN = CD4+ T cell from the lymph nodes, EryBLPO = ortho and poly erythroblasts. Where multiple classes exist for a cell type,
the genotype and strain are highlighted. C57 =WT C57BL/6, BALB =WT BALB/c, and IL-5 = IL5T BALB/c. All other cells are on a WT C57BL/6
background. Expression levels in (i) and (iii) are colored according to absolute expression of genes on a log2 scale. Gene setswith distinct expression
patterns during hematopoiesis are highlighted. On (A) a granule protein gene, Ear2, and cell cycle genes are labeled on the plot, on (B) mature cell
and eosinophil restricted transcription factors are highlighted. (C) qPCR validation of expression changes of selected genes from (A) and (B). (i)
Expression levels in IL5T eosinophil populations from microarray data. (ii) qPCR expression levels. Scales are log or linear as indicated, depending
on data range. Each dot represents an independent replicate (for microarray each replicate is a pool of mice, for qPCR each replicate is a single
mouse). Mean± SD. *p< 0.05
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F IGURE 4 Cell cycle status in eosinophil lineage populations. (A) Relative expression of E2F family probes in BALB/c IL5T progenitors and
eosinophils. Where gene names are shown twice, the gene was detected with multiple probes. Expression values are normalized to show relative
expression of each probe and differences in gene expression are shown on a log2 scale. (B) Representative flow cytometry plots of eosinophil
lineage populations from Fucci mice with proportions of cells in each gate. Schema of how staining corresponds with cell cycle stage as defined
in Tomura et al.25 is shown. (C) Quantification of Fucci cell cycle data. Plots show mean ± SD (n = 3 indivdual mice). Significance is shown for EoP
versus EoM BM and EoM BM versus EoH PB. *p < 0.05. (D) Quantification of S/G2/M phase (>2NDNA content) in eosinophil lineage populations
by DAPI staining. Mean ± SD (n = 4 individual IL5T C57BL/6 mice). Significance is shown for EoP versus EoM BM and EoM BM versus EoH PB.
*p < 0.05. (E) Representative histograms of DAPI staining levels by flow cytometry to indicate DNA content of each eosinophil lineage population.
Peak represents 2NDNA content (G1/G0), with themarker covering>2N (S/G2/M phases)
to a lower ability to detect key genes. We reasoned that this would
identify key trajectory genes, without being unduly restrictive. We
selected genes that were significantly up- or down-regulated with a
log2 fold change of at least 0.5. Using this approach, we identified 330
up-regulated genes (353 probes; Fig. 3A(i)) and 271 down-regulated
genes (290 probes; Fig. 3B(i)) that were significantly altered across
the eosinophil trajectory (Supplementary Tables 1 and 2). Expression
profiles of 4 such trajectory genes (Ramp1, Cebpb, Tlr4, and Trem14)
were validated using RT qPCR (Fig. 3C).Moreover, therewas high con-
cordance with our data and published WT BALB/c RNASeq data gen-
erated by the Fulkerson laboratory21 comparing EoPs to eosinophils
(Fig. 3A(ii) and B(ii)). Of our 601 DE genes, 261 were significantly DE
in the same direction with at least a log2 fold change of 0.5, and only
8 were significantly DE in the opposite direction (Fig. 3A(ii) and B(ii)).
FAIRFAX ET AL. 201
To investigate if trajectory gene expression changes were specific to
eosinophils or occurred generally during hematopoietic differentia-
tion, we examined their expression in a broad range of hematopoi-
etic cells20 (Fig. 3A(iii) and B(iii)). Down-regulated eosinophil trajec-
tory genes generally had higher expression in progenitors thanmature
cells, implying general functions within progenitors and stem cells that
are down-regulated with differentiation into various lineages. Down-
regulated trajectory genes could be separated into 3 broad classes
by expression pattern—those that were expressed in many cell types
(ubiquitous), those that were expressed more highly in progenitors,
and those that were expressed at higher levels in EoPs (denoted as
early eosinophil, Fig. 3A(iii)).
We also examined the expression of up-regulated eosinophil
trajectory genes across wider hematopoiesis and found that the
majority of them had their expression restricted to particular cell
types. We grouped them into 3 categories: genes with ubiquitous
expression, those thatweremorehighly expressed inmature cell types,
and those that weremore restricted to eosinophils (Fig. 3B(iii)).
We further examined up-regulated trajectory genes with restricted
expression inmature cells andeosinophils as thesewere themost likely
to have functional importance. In the mature cell set, we found 9 tran-
scription factors. These included Ikzf3 (Aiolos), Nod2, Bcl3, and Foxo1,
which are reportedly induced in eosinophil maturation.21 Ikzf3 bind-
ing sites have also been shown to be enriched in active genes regulated
during eosinophil development.21
Six eosinophil specific transcription factors—Arnt, Crtc1, Hic1,
Hoxc9, Zfp689, and Zfp282—were also found to be up-regulated
(Fig. 3B). Crtc1 is known to be up-regulated from WT EoPs to
eosinophils21 and theother factorsmayhave roles in IL-5 response and
the processes associated with eosinophil lineage progression.
To discover more about the function of eosinophil trajectory genes,
we tested gene sets derived from gene ontology (GO) terms sourced
from MSigDB22 with Fisher’s exact test for overrepresentation. Mul-
tiple GO terms associated with the “cell cycle” (genes including Cdk1,
Cdca3, and mini-chromosome maintenance genes) were statistically
overrepresented in down-regulated trajectory genes, whereas “nega-
tive regulation of the cell cycle” (including the cyclin-dependent kinase
inhibitor encoding genes Cdkn2a and Cdkn2b) was overrepresented
in the up-regulated trajectory genes. Moreover, subsequent testing
of trajectory gene sets for overrepresentation of transcription factor
bindingmotifs revealed enrichment for the E2F family (Fig. 4A), known
to play a key role in cell cycle regulation.23 Together, these data are
consistent with cell cycle arrest and entry into quiescence across the
eosinophil trajectory.
To test directly whether EoP, EoM, and EoH populations differed
in terms of cell cycle in vivo, we assayed these populations by flow
cytometry. In the WT context, we examined eosinophils from trans-
genic Fucci mice,17 in which fluorescent reporters had been linked to
proteins Cdt1 and geminin that oscillate inversely during the cell cycle.
Cdt1, linked to Kusabira Orange, accumulates during G1 and G0 and is
promptly degraded at the onset of S-phase. Geminin, fused to Azami-
Green, accumulates in S/G2/M phases, and is degraded at the com-
pletion of mitosis.17,24 In Fucci mice, EoP, EoM, and EoH cells signifi-
cantly differed in their cell cycle distribution (Fig. 4B andC). EoPswere
F IGURE 5 Granule protein production in IL5T eosinophils. (A)
Heatmap of granule protein gene expression in IL5T eosinophils.
Where gene names are shown twice, the gene was detected with mul-
tiple probes. n for each population as shown in Fig. 2A. Expression val-
ues are normalized to show relative expression of each gene anddiffer-
ences in gene expression are shown on a log2 scale. (B) Comparison of
(i) Epx expression in IL5T eosinophil populations frommicroarray data.
(Values are shown on a linear scale) to (ii) ELISA of EPX production by
IL5T eosinophil populations showing relative EPX concentration in
each population. Error bars show mean ± SEM. (C) Comparison of (i)
Ccr3 transcript levelsmeasured bymicroarray to (ii) CCR3 surface pro-
tein levels measured by flow cytometry. Mean+ SEM
mostly in early and late G1 (consistent with active, albeit slow cycling),
whereas EoH in the BM and eosinophils in the PB were almost exclu-
sively inG0 (consistentwith cell cycle exit
25). Interestingly, a clear pop-
ulation of cycling (S/ G2/M and early/late G1) EoM cells were present
in the BM.
As IL5Tmice were not available on the Fucci background, we exam-
ined the DNA content in IL5T eosinophil populations with DAPI to
assess cell cycling (Fig. 4D and E). Again, we see that EoP and EoM in
the BM have a significant population with >2N DNA content (denot-
ing cells in S/G2/M phases), whereas EoH BM and PB eosinophils
had almost exclusively 2N content and were likely in G1/G0 arrest.
Together, these data demonstrate that cells become quiescent as they
progress along the eosinophil trajectory, and that EoP, EoH, and EoM
differ in terms of their cell cycle profiles.
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F IGURE 6 Transcriptional differences between wild type (WT) and IL5T progenitors. (A) Venn diagram showing overlap of differentially
expressed (DE) genes (FDR < 0.05) between WT BALB/c and IL5T BALB/c progenitor populations. (B) Schema showing division of IL-5 respon-
sive genes in EoPs (BALB/c EoP v IL5T BALB/c EoP) into 3 groups as shown on the Venn diagram. (C) DE genes between WT BALB/c and IL5T
BALB/c EoPs. Expression in individual replicates of these cell types is shown to the left. Average expression in relevant cell types for these compar-
isons is shown to the right. Genes are grouped according to the scheme in (B). Numbers of probes in each group are listed on the left and select gene
names are shown on the right. Full details of genes are given in Supplementary Tables 1 and 3. Heatmap is colored according to mean normalized
expression. Genotypes labeled BALB/c=WTBALB/c, C57=WTC57BL/6, and IL5T= IL5T BALB/c. FDR< 0.05 for all comparisons
3.3 Granule protein production in IL5Tmice
The production and release of granule components, including the
cytotoxic proteins eosinophil peroxidase (EPX), major basic pro-
tein, and eosinophil associated RNAses, are central to eosinophil
function. Analysis of transcript expression for genes associated
with granules in IL5T mice (Fig. 5A) peaks when cells are in the
BM, consistent with that reported in WT mice.21 For some granule
genes (Rnase2b, Ear2, and Epx), transcription peaks in EoPs and
markedly drops as cells progress through the trajectory, whereas
other granule components (prg2 and Ear1) reach peak expression
in EoMBM.
To compare the pattern of transcript production to protein storage,
we performed an EPX ELISA on IL5T eosinophil populations (Fig. 5B).
EPX protein levels were not significantly different between these pop-
ulations. This supports the notion that EPX production occurs early in
eosinophil development in theBMand is then stored until it is required
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in the periphery. This is in contrast to the expression of the CCR3, the
eotaxin receptor, which has the levels of protein surface expression
more correlated with its transcript levels (Fig. 5C).
3.4 Effects of constitutive IL-5 on EoPs
EoPs express IL-5R𝛼 and are responsive to IL-5 stimulation. Gene
expression changes have been examined in BM cells cultured in vitro
with IL-5,26 but little is known about the transcriptional differences
caused in eosinophil progenitors by chronic IL-5 stimulation in vivo.
We therefore compared the transcription profiles of EoPs, CMPs, and
GMPs isolated from IL5T to their counterparts fromWTmice. In EoPs,
the influence of IL-5 stimulation was prominent with 325 DE probes
(Fig. 6A), as opposed to the few significantly DE genes in the CMPs
and GMPs (51 and 11 probes, respectively, at a false discovery rate of
<0.05), suggesting IL-5 stimulation has a major influence on cells com-
mitted to the eosinophil lineage.
We examined the expression of EoP IL-5-responsive genes in the
eosinophil-committed section of the eosinophil trajectory (fromEoP to
EoH PB; Fig. 6B and C). There were 3 major groups of genes (Fig. 6C):
(1) those that were DE from EoP to eosinophils, which we considered
associated with maturation, (2) those that were generally IL-5 respon-
sive, that is, not DE during maturation but also DE between WT and
IL5T eosinophils—termed IL-5 shared, and (3) those which did not fall
into either previous category, so were only responsive to IL-5 in EoPs
(Supplementary Tables 1 and 3).
More than half the differential expression (58%) is due to specific
effects of IL-5 on EoPs, with few genes DE due to a general IL-5 effect
on both EoPs and eosinophils. A total of 33% of the EoP IL-5 respon-
sive genes were associated with eosinophil maturation including
down-regulation of cytokine signaling genes Il12a, Il17rb, Il15, Il31ra,
Cd72, and Stat4.
Notably, genes involved in granule productionwerenot significantly
affected by IL-5 stimulation in EoPs, despite being an early sign of EoP
differentiation from less committed progenitors.
In summary, our data show that there are 2 different populations
of eosinophils in IL5T and WT mice by Siglec-F expression, which are
transcriptionally distinct and differ in cell cycle profile. These popula-
tions follow a linear trajectory as assessed by transcriptional changes
from EoP to EoM to EoH in the BM, and then to EoH in the periphery,
and even among the eosinophils there is a gradient of cell cycle status,
with cells trending towardquiescence.Our analyses provide a key plat-
form for discovery of potential eosinophil lineage-specific genes (such
as the transcription factors Arnt, Hic1,Hoxc9, Zfp689, and Zfp282) that
have been revealed by assessing the transcriptional changes that occur
across the eosinophil trajectory.
Our dataset is presented as a resource to the eosinophil community
and it enables comparison of several eosinophil and progenitor sub-
setsondifferent genetic backgrounds.Wehaveprovided theoutcomes
of relevant comparisons in Supplementary Tables 1–3. Raw transcrip-
tional data are available to download fromGEO (GSE112010) or it can
be directly visualized and compared to a comprehensive collection of
hematopoietic cell types from diverse lineages at haemopedia.org.
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